Cargando…

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives

BACKGROUND AND OBJECTIVE: In recent years, the application of less-invasive “bladder-sparing” trimodal therapy (TMT) in selected muscle-invasive bladder cancer (MIBC) patients unfit for or who declined radical cystectomy (RC) has been increasing. This review aims to summarize the current evidence an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xinxiang, He, Wang, Huang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251081/ https://www.ncbi.nlm.nih.gov/pubmed/37305635 http://dx.doi.org/10.21037/tau-23-124

Ejemplares similares

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
por: Tholomier, Côme, et al.
Publicado: (2020)

Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
por: Kim, In-Ho, et al.
Publicado: (2021)

AB007. Bladder-sparing treatments for muscle-invasive bladder cancer
por: Li, Shengwen, et al.
Publicado: (2017)

Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review
por: Lemiński, Artur, et al.
Publicado: (2023)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)

Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
por: Koga, Fumitaka
Publicado: (2020)

Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2023)

Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise
por: Darwiche, Fadi, et al.
Publicado: (2015)

Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments
por: Goldberg, Ilana P., et al.
Publicado: (2022)

The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer
por: Shi, Ying, et al.
Publicado: (2023)

Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
por: Lee, Cheng-Yen, et al.
Publicado: (2014)

Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
por: Shi, Hongzhe, et al.
Publicado: (2021)

Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends
por: Shalata, Aya T., et al.
Publicado: (2022)

Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives
por: Wołącewicz, Mikołaj, et al.
Publicado: (2020)

Health Related Quality of life in bladder cancer. Current approach and future perspectives
por: TRUTA, ANAMARIA, et al.
Publicado: (2017)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions
por: Sun, Xinghui, et al.
Publicado: (2023)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer
por: Uchida, Yusuke, et al.
Publicado: (2023)

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
por: Tan, Wei Shen, et al.
Publicado: (2023)

Tissue Engineering of the Urinary Bladder: Current Concepts and Future Perspectives
por: Petrovic, Vladimir, et al.
Publicado: (2011)

Current Applications and Future Directions of Bioengineering Approaches for Bladder Augmentation and Reconstruction
por: Wang, Xuesheng, et al.
Publicado: (2021)

Current status of laparoscopic and robot-assisted nerve-sparing radical cystectomy in male patients
por: Huang, Jian, et al.
Publicado: (2016)

Bladder neck sparing in radical prostatectomy
por: Smolski, Michal, et al.
Publicado: (2013)

Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
por: Tratnjek, Larisa, et al.
Publicado: (2021)

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021)

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
por: Douglass, Laura, et al.
Publicado: (2016)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

Tissue engineering of urinary bladder – current state of art and future perspectives
por: Adamowicz, Jan, et al.
Publicado: (2013)

Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
por: Ueda, Tomohiro, et al.
Publicado: (2021)

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer
por: Xu, Chao, et al.
Publicado: (2023)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Emerging perioperative therapeutic approaches in muscle invasive bladder cancer
por: Patil, Goutham, et al.
Publicado: (2022)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8h31cs5v7gk9073l87ei34lmbe